Application Nr Approved Date Route Status External Links
NDA203414 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Alogliptin And Metformin Hcl Tablets Are A Dipeptidyl-Peptidase-4 (Dpp-4) Inhibitor And A Biguanide Combination Product Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1.1 ) Important Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1.1 ) 1.1 Monotherapy And Combination Therapy Alogliptin And Metformin Hcl Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus When Treatment With Both Alogliptin And Metformin Is Appropriate [See Clinical Studies (14) ] . Important Limitations Of Use Alogliptin And Metformin Hcl Tablets Are Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Alogliptin Benzoate ALOGLIPTIN BENZOATE ZINC1011
2. Metformin Hydrochloride METFORMIN HYDROCHLORIDE ZINC12859773

Comments